Chen Zhu, General Consultant of Innovation Research, Vice Chairman of the Standing Committee of the 13th National People's Congress and Academician of the Chinese Academy of Sciences, and Jin Li, President of Fudan University and Academician of the Chinese Academy of Sciences, took a group photo at the inauguration ceremony of the Alliance
In the era of digital and intelligent economy, precision medicine, as an important development direction of medicine, has attracted great attention from the government, medical circles, science and technology circles, and industry circles.
At the right time, the 2024 Precision Medicine Research and Industry Development Conference will be held at the Shanghai International Convention Center from September 6 to 8. The theme of the conference is "Improving the Ecology of Precision Medicine Achievement Transformation and Accelerating the Formation of New Health Productivity".
During the conference, the Precision Medicine Research and Industry Development Alliance, R&D Ke and Yuanmo Health will invite startups in the fields of medicine, innovative drugs and device diagnostics to participate in the innovation competition.
This competition aims to help outstanding pharmaceutical and medical device companies in the field of precision medicine better connect with medical, capital and industrial resources, so that innovative ideas can be turned into cures faster, so as to promote scientific and technological research, achievement transformation and industrial development of precision medicine.
The companies that are finally qualified for the roadshow will receive professional guidance from 30 senior judges from leading enterprises in the medical and health field, investment institutions and medical circles, who will escort the company's roadshow and campaign.
In addition, the roadshow company will also have the opportunity to participate in other project training initiated by the Precision Medicine Research and Industry Development Alliance, as well as get the opportunity to speak at the DJSeedin Innovation Cooperation Summit hosted by R&D customers in 2025.
Winners of the competition will be rewarded
First Prize: 50% tuition fee waiver for the Alliance Advanced Training Course (the first module of the third phase of the Alliance Innovation and Empowerment Advanced Training Course will be held at Tsinghua University); Skip the screening process and go straight to Imperial College London to participate in the "Health Systems Innovation: From Leadership to Practice" training program at your own expense.
2nd-5th place: Participate in the 2024 Precision Medicine Research and Industry Development Conference, speak at sub-forums or be a guest discussant.
All winners: introduce the funds and park exchanges that cooperate with the alliance, and get closer to the fund units with abundant funds and top investors.
The Precision Medicine Research and Industry Development Alliance was initiated and established on March 28, 2023 by 12 institutions including Shanghai Medical Innovation and Development Foundation and Tsinghua University Hospital Management Research Institute, 16 academicians, experts and general consultants of innovative research, vice chairman of the Standing Committee of the 13th National People's Congress and academician of the Chinese Academy of Sciences, Jin Li, president of Fudan University and academician of the Chinese Academy of Sciences, Chen Saijuan, academician of the Chinese Academy of Engineering, director of the National Center for Translational Medicine (Shanghai), and former chairman of the Shanghai Association for Science and Technology.
The organizing committee of the event sincerely invites outstanding pharmaceutical and medical device companies in the field of precision medicine to participate in the roadshow selection, and looks forward to gathering in Shanghai in September to discuss development.
Contest judges
Clinical Institution Judges:
Luo Zhe is the director of the ICU of Zhongshan Hospital affiliated to Fudan University
Liu Xianbao is the Vice President of the Heart Hospital of the Second Affiliated Hospital of Zhejiang University School of Medicine
Hu Guoyong is Vice President of the First People's Hospital of Shanghai Jiao Tong University
Clinical & Translational Judges:
Cao Qing, Department of Discipline Planning and Large Facilities Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Judges of Investment Institutions:
Daniel Zhang, Co-founder and Managing Partner of Lize Capital
Yibo Cao, Managing Director of Sequoia China
Yuexin Zhou, Managing Director of Nest Capital
Wu Aimin is the Managing Partner and President of One Capital
Yan Shixiang is a partner of Materia Medica Capital
Liu Yuwen is the founding partner of Bohe Angel Fund and the founder of Newnest Innovation Center & Bohe Innovation Center
Corporate Judges:
An Meng is the Chairman of the Board of Directors of Consun Pharmaceutical
Rong Wang, head of Eli Lilly's China Innovation Cooperation Center
Judges from Industry Bodies:
Wang Wei is the Director of Healthcare Industry Development at Huawei Strategy Research Institute
(The judges continue to be invited~)
How to Enter
Preparation Materials: Latest Unconfidential Business Plan • Introduction to the Founding Team • Business Value – What Clinical Problems to Solve? • Technology Platform Competitiveness – Where is your moat?
Please send BP to the following email address:
Dai Jialing Email: [email protected]
WeChat: Dai-Jialing
Zhou Chen Yige
Email: [email protected]
WeChat: -Zzzzz_ii
Cheng Long
Email: [email protected]
微信: qijiangheCL
Timing
Open call: June to the end of July 2024
Preliminary screening: August 2024
On-site roadshow and selection: September 6-8, 2024
Tournament Schedule
On September 6, the on-site roadshow and selection of alliance projects
September 7 series of closed-door meetings
On September 8, the main forum of the conference in the morning, and the roadshow and sub-forums of the conference project in the afternoon
Address of the conference
Shanghai International Convention Center (2727 Binjiang Avenue, Pudong New Area, Shanghai)
Organizers and organizers
Organizer: Precision Medicine Research and Industry Development Alliance
Organizer:
About the Precision Medicine Research and Industry Development Alliance
The Precision Medicine Research and Industry Development Alliance was initiated and established on March 28, 2023 by 12 institutions including the Shanghai Medical Innovation and Development Foundation and the Hospital Management Research Institute of Tsinghua University, 16 academicians, experts and chief consultants of innovative research, Chen Zhu, vice chairman of the Standing Committee of the 13th National People's Congress and academician of the Chinese Academy of Sciences, Jin Li, president of Fudan University and academician of the Chinese Academy of Sciences, Chen Saijuan, director of the National Center for Translational Medicine (Shanghai), former chairman of the Shanghai Association for Science and Technology, and academician of the Chinese Academy of Engineering.
Since its establishment, the alliance has actively carried out a series of actions in three aspects: [Precision Medicine Original Research], [Precision Medicine Development Fund], and [Innovation Empowerment Advanced Training Course], and successfully held the "2023 Precision Medicine Research and Industry Development Forum", built a seven-in-one cooperation platform and network of "government-industry-academia-research-medical-capital-application", and formed an ecology of "precision medicine innovation research and industrial development".
About Yuanmo Health
Shanghai Yuanmo Health Management Co., Ltd. (hereinafter referred to as Yuanmo Health): Founded in 2020, it will become a high-tech enterprise in Shanghai in December 2023. Yuanmo Health is committed to building a medical ecology in the digital era, using digital technology and innovative ideas.
Since its establishment, Yuanmo Health has supported a number of national medical staff training programs and innovative medical policy and technology pilots, and has accumulated rich experience. At this stage, Yuanmo Health's business is mainly in two fields: the Yuanmo Online Medical School based on Internet thinking and the Yuanmo Research Institute based on cutting-edge technology research. Among them, Yuanmo Online Medical School focuses on the education and empowerment platform of pediatrics, ophthalmology, traditional Chinese medicine, brain health and geriatric-related diseases; Yuanmo Research Institute is committed to becoming a cutting-edge technology analysis, industrial development and incubation platform for precision medicine.
In 2023, Yuanmo Health, Tsinghua University Hospital Management Research Institute, Peking University School of Future Technology, Beijing Tiantan Hospital affiliated to Capital Medical University, Shanghai Jiao Tong University Medical Robot Research Institute, China Association of Enterprises with Foreign Investment and other 12 units jointly initiated the establishment of the "International Precision Medicine Research and Industry Development Alliance".
About R&D
Founded in 2014 by senior journalists and editors, R&D has become an authoritative and diversified platform for China's pharmaceutical industry, including all-media information, research institutes, industry summits and communication consulting training. Our focus areas span the entire drug lifecycle, from scientific translation, early drug development to clinical development, commercial pricing, as well as market entry strategies, PR and communications strategies.
At present, the R&D customer all-media information platform covers the official accounts of Chinese and English platforms such as websites, WeChat public accounts, Xueqiu, Toutiao, LinkedIn, etc., and is a resident senior editor and writer in Shanghai, Guangzhou, Beijing, Suzhou, and New Jersey, USA, and has launched a number of influential columns. Through research, research and reporting, we hope to become a beacon for China's pharmaceutical industry.